Screener
Opko Health OPK Pharmaceutical — Goodwill Impaired Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) | 2026 / Grossgoodwill at January 1,2026 | 2026 / Cumulativeimpairmentat January 1 | 2026 / Foreignexchangeand other | 2026 / Balance at June 30, 2026 |
|---|---|---|---|---|
| Pharmaceuticals | ||||
| CURNA | $4,827 | $(4,827) | — | — |
| Rayaldee | 89,510 | — | (2,473) | 87,037 |
| FineTech | 11,698 | (11,698) | — | — |
| ModeX | 80,260 | — | — | 80,260 |
| OPKO Biologics | 139,784 | — | — | 139,784 |
| OPKO Chile | 3,553 | — | (82) | 3,471 |
| OPKO Health Europe | 7,740 | — | (219) | 7,521 |
Item 1. Financial Statements
FAQ
- What is Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss?
- Opko Health (OPK) reported pharmaceutical — goodwill impaired accumulated impairment loss of $11.7M in Q2 2026.
- How has Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss changed year-over-year?
- Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss decreased by 0.0% year-over-year, from $11.7M to $11.7M.
- What does pharmaceutical — goodwill impaired accumulated impairment loss mean?
- The cumulative total of impairment losses recognized against goodwill specifically allocated to the pharmaceutical segment. This reflects historical write-downs taken when the carrying value of the segment's goodwill exceeded its implied fair value.
Ask your AI about Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude